RT Journal Article
SR Electronic
T1 Prognostic significance of compound physiology variables in oesophageal cancer
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.16.20067769
DO 10.1101/2020.04.16.20067769
A1 Powell, Arfon G M T
A1 Eley, Catherine
A1 Coxon, Alexandra H
A1 Chin, Carven
A1 Bailey, Damian M
A1 Lewis, Wyn G
A1 ,
YR 2020
UL http://medrxiv.org/content/early/2020/04/19/2020.04.16.20067769.abstract
AB Aims Objective identification of patient risk profile in Oesophageal Cancer (OC) surgery is critical. This study aimed to evaluate to what extent cardiorespiratory fitness and select metabolic factors predict clinical outcome.Methods Consecutive 186 patients were recruited (median age 69 yr. 160 male, 138 neoadjuvant therapy). All underwent pre-operative cardiopulmonary exercise testing to determine peak oxygen uptake , anaerobic threshold (AT), and ventilatory equivalent for carbon dioxide . Cephalic venous blood was assayed for serum C-reactive protein (CRP), albumin, and full blood count. Primary outcome measures were Morbidity Severity Score (MSS), and Overall Survival (OS).Results MSS (Clavien-Dindo >2) developed in 33 (17.7%) and was related to elevated CRP (AUC 0.69, p=0.001) and lower V·O2Peak (AUC 0.33, p=0.003). Dichotomisation of CRP (above 10mg/L) and V·O2Peak (below 18.6mL/kg/min) yielded adjusted Odds Ratios (OR) for MSS CD>2, of 4.01 (p=0.002) and 3.74 (p=0.002) respectively. OC recurrence occurred in 36 (19.4%) and 69 (37.1%) patients died. On multivariable analysis; pTNM stage (Hazard Ratio (HR) 2.20, p=0.001), poor differentiation (HR 2.20, p=0.010), resection margin positivity (HR 2.33, p=0.021), and MSS (HR 4.56, p<0.001) were associated with OS.Conclusions CRP and V·O2Peak are collective independent risk factors that can account for over half of OC survival variance.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesQueries and requests for data can be made to the corresponding author